Unofficial. This site is an experimental reformatting of data published by NHS England. It is not endorsed by NHS England. Always check the official Data Uses Register before relying on anything here.

Exploring the mechanisms through which specialist home visiting produces health and well-being benefits for families.

Cardiff University · Academic

In term In term in the September 2026 edition: the latest version runs to 22 February 2027.

Reference
DARS-NIC-374907-Q5W5W
Current version
v3.2
Term of current version
23 February 2026 to 22 February 2027
Start date
1 November 2020
Data controller
Joint Data Controller
Commercial purposes
No
Sublicensing
No
Files released to date
0

Data controllers

Why the data was released

Objective for processing

BACKGROUND

(i) Specialist home visiting to support new families:

The Family Nurse Partnership (FNP) was developed and licensed by the University of Colorado as a voluntary, preventive programme for vulnerable young first time mothers. It offers intensive and structured home visiting, delivered by specially trained nurses, from early pregnancy until age two. The three aims are: to improve pregnancy outcomes, improve child health and development and improve parents’ economic self-sufficiency.

A strong and rigorous US evidence base, developed over 30 years, has shown FNP benefits the neediest young families in the short, medium, and long term across a wide range of outcomes helping improve social mobility and break the cycle of inter-generational disadvantage and poverty.

(ii) Work to establish the programme in the UK and the Cardiff evaluations:

The programme was adapted for implementation and introduced in England in 2007. Due to the greatly differing nature of publicly funded health and social care service provision and socio-cultural context between England and the US, the relative benefits of the programme need to be replicated in England and costs determined before wide-spread implementation can be recommended. The study team have conducted two definitive evaluations:

BB:0-2 - Department of Health and Social Care (DHSC) commissioned the ‘Building Blocks’ randomised controlled trial (RCT) from Cardiff University to provide independent evidence on the effectiveness of the FNP programme in improving short term outcomes for young parents and their babies. The trial began in 2009 and the findings which cover the period from pregnancy to the child’s second birthday' were published in October 2015. The FNP described these as “important early findings and add to the evidence the study team have from the US, Netherlands and other early evaluation in England to help improve FNP in England.”

BB: 2-6 - The National Institute of Health Research further funded Cardiff University to undertake a follow up study to examine child and maternal outcomes to age six. This built on the original study to examine the longer-term impact of FNP intervention. Its principal objective was to determine the effectiveness of the FNP programme in reducing objectively measured long-term maltreatment outcomes when compared to usually provided health and social care alone. The main research outcomes were child in need status, child protection registration, referral to social care. Other indicators of programme impact included measures of injuries and ingestions and hospital DNA rates. The study report has been externally peer reviewed and was published by NIHR in February 2021: https://www.journalslibrary.nihr.ac.uk/phr/phr09020/#/full-report.

The main journal article is published here: https://bmjopen.bmj.com/content/bmjopen/12/2/e049960.full.pdf

In the BB:2-6 study, Cardiff University followed-up the cohort of mothers and children who took part in the first Building Blocks trial (BB:0-2) by obtaining health and mortality data from NHS England, data from Department for Education (DfE) and data from the Department of Health (abortion statistics) and linked with the original trial data.

(iii) Evidence from the Cardiff work and NHS England supplied data to date

The original Building Blocks trial (BB:0-2) provided evidence for the short-term effectiveness of the programme (up to 2 years after birth). The Building Blocks: 2-6 (BB:2-6) study has now provided evidence for the medium-term effectiveness and costs of one of the most promising early intervention programmes for reducing risk of child maltreatment in a targeted vulnerable population. Specifically, data requested from NHS England provided the basis for key study outcomes which are indicators of maltreatment. Both studies have provided evidence which has informed policy decision-making at both national and local level about whether to continue implementing the programme and also changes to programme content, format and delivery.

OBJECTIVES OF THIS STUDY

In 2019/20, the study team received additional funding to analyse pseudonymised study data already held in the data safe haven (which includes NHS England supplied data provided under DARS-NIC-333498-D1K7G). These analyses explore the mechanisms by which specialist home visiting may have its effect for recipient families. Two funders (Nuffield Foundation, European Research Council (ERC)) provided resources to support the two separate analyses both of which utilise the same existing data set.

Proposed analyses funded by ERC and Nuffield Trust:

The analyses explore the mechanisms by which specialist home visiting may have its effect for recipient families. The analyses to date have determined the impact of the home visiting intervention upon a wide range of family outcomes. These range from the antenatal period through to early in children’s school life (i.e. at key stage 1). The study team explored how home visiting has benefited some families but has been less effective for others. The study team also assessed the additional benefit that receiving more home visits has had for some of the more important outcomes that have been assessed. The study team explored the perceptions of both mothers and family nurses (i.e. the professionals who deliver home visits to families) about how the home visiting may exert its effect (and what may be a barrier to its effectiveness). The study team explored how some outcomes (such as children being designated as In Need by local departments of children’s services) are influenced by a range of potential risk factors (for example, attributes of the mother and child).

The analysis takes an econometric approach to explore how the benefits of the home visiting intervention are produced. The study explores the mechanisms through which the home visiting intervention is hypothesised to produce benefits (for example, whether expected changes in maternal behaviour occur and whether these then lead to other improvements). The study explores how characteristics of nurses plays any part in observed effects (for example, whether some nurses are associated with more or less improvement. This may be due to differences in clinical experience or training, for example). It explores further how home visiting dose and quality may be linked to differential family benefits (visit-level data available for each mother in receipt of specialist home-visiting provides detail on how many visits were delivered, their duration and the content addressed using the scheme’s standard monitoring form). Finally, the study assesses how reported use of other public sector services may also have an influence. The existing trial cohort data (including Data provided by NHS England) has been analysed using state-of-the-art economics methods, benefiting from the input of the lead investigator who secured the additional funding. The analysis dynamically models the study data to establish more clearly than has been possible previously how the home visiting programme produces benefits for families.

The two analyses (Nuffield and ERC) use an existing pseudonymised data set supplied by NHS England under DARS-NIC-333498-D1K7G-v4.4. The first (Nuffield), involves two similar study cohorts being assessed in the new analyses (the other being from a study in Germany which implemented a similar intervention). The analyses for the two cohorts run in parallel (i.e. the data will remain where currently located) but similar research questions were asked of the two study datasets. NHS England Data held by Cardiff as data controller will not be shared or linked to the German data. Only derived outputs are compared when interpreting the outputs from the two analyses. The second funded analysis (ERC) involves a broader range of data drawn from a variety of sources these include: distance from / price of / availability of goods and services for children (e.g. price of toys, distance from GP/parks, food prices); and prices of cigarettes, alcohol and local wages. Like the Nuffield funded work, the ERC analyses involve data from the Building Blocks trial cohort being analysed separately from any other project data but will share a common underlying research question and specialist economics methods. For the analysis of the Building Blocks dataset more detailed exploration of (non-NHS) trial data based on existing post code is used to determine the role of local context (including policies) upon family outcomes, no attempt will made to identify or link the data.

The two project grants are led by a member of staff at UCL and the analyses is undertaken by the research fellow and themselves, both of whom are substantive employees of UCL. Access to the Data is approved by the study lead at Cardiff University. All analyses is reviewed and approved by the study lead at Cardiff University. This study lead is the chief investigator and is costed into both grants to provide these approvals and oversee all outputs from the study. A statistician based in Cardiff and approved to access the cohort dataset has responsibility to review the statistical analysis plan for both Nuffield and ERC-funded studies.

Cardiff University was the Controller (and sponsor) of the original study and Swansea University (and Cardiff University) were Processors, however Swansea are no-longer involved in any capacity. This agreement includes UCL as a joint controller who processes data. UCL make decisions on the manner of data processing, and the two project grants are led by a member of staff from UCL. The additional funded work is funded by both the European Research Council and Nuffield Trust. Neither body may make decisions related to how the data are processed and will not have access to the data. The Chair of the Information Governance Review Panel at SAIL (Swansea University) confirmed that as the data being accessed in relation to the study are appropriately anonymised, no further ethical review was required.

The UK GDPR legal basis for processing NHS England data are: Article 6:1(e):This project is a task in the public interest because it was commissioned by the Department of Health to evaluate the impact of home-visiting interventions on child maltreatment; and, Article 9:2(j):This is scientific research which uses only the data required to answer these important research aims, using a data safe haven to protect the data and outputs this research will directly influence policy making regarding home visiting programmes to benefit the UK public.

DATA SUBJECTS

The cohort consists of 1645 women (and their first-born child(ren)) who met eligibility criteria for participation in the Building Blocks trial of the Family Nurse Partnership (FNP) and were nulliparous (a woman who has never given birth either by choice or for any other reason. This term also applies to women who have given birth to a stillborn baby, or a baby who was otherwise not able to survive outside the womb) women aged 19 or under, living in one of 18 local authority FNP catchment areas in England who were recruited by 24+6 weeks gestation, had conversational level of English and were able to consent to research.

Women were recruited by locally-based research professionals usually employed by local NHS organisations following identification through NHS maternity units. Women provided their written informed consent to participate including for data in their administrative health records to be provided to the research team.

Relevant Data for the study cohort provided by NHS England under DARS-NIC-333498-D1K7G-v4.4 include: Civil Registrations of Death; Hospital Episode Statistics A&E; Outpatients; and, Admitted Patient Care. These data were used to follow-up mothers recruited into the study and their babies, up until the baby’s second birthday. These datasets are the main source of data for two of the primary outcomes (and several secondary outcomes).

The BB:0-2 trial began in 2009 and the findings which cover the period from pregnancy to the child’s second birthday' were published in October 2015 and available here: https://doi.org/10.1016/S0140-6736(15)00392-X

The National Institute of Health Research funded BB:2-6 study follow up study examined child outcomes to age six, building on the original study examining the longer term impact of FNP intervention. A subsequent application for data from NHS England (DARS-NIC-333498-D1K7G) permitted collection of the same health data for an additional four years, until the mother’s first child(ren) was aged six years old. As identifiable data were required to enable linkage of the original trial cohort data to these new records, section 251 approval was given.

The Building Blocks study originally involved a lay group who advised on aspects of trial delivery and provided input into the design and setup of the study. An independent group of young people also provided advice to the research team and a lay perspective on the general management and delivery of the project and in particular the preparation of the outputs from the study.

Processing activities

All data transfers have concluded and there are no further flows of data. Historically, the Data was analysed in the SAIL data safe haven at Swansea University. The NHSE Data was securely transferred from Swansea University to Cardiff University on 09/02/2024. Swansea are no-longer involved in any capacity.

There is no requirement and there will be no attempt to reidentify the individuals in the cohort. Data already supplied by NHS England under DARS-NIC-333498-D1K7G-v4 are described in the Products section of this Agreement for clarity.

Cardiff University provided the following fields to NHS England under DARS-NIC-333498-D1K7G-v4 to enable tracing of the cohort :

• Study ID

• NHS Number

• Date of Birth

• Sex

• Postcode

Under agreement DARS-NIC-333498-D1K7G-v4, NHS England linked this information to the HES and mortality data, stripped out the identifiers and returned a pseudonymised output to the data processor, the Swansea University’s Secure Anonymised Information Linkage (SAIL) Databank. Cardiff University also sent SAIL a copy of the original study (BB:0-2) data and separately sent participant identifiers to the Department for Education which supplied linked pseudonymised data from its records to SAIL. Data was requested and approved from the Department of Health abortion statistics team to link to the mothers in this cohort. The study used the abortion data to calculate whether a mother had a subsequent pregnancy and the study created a composite outcome which was used to report the rates of subsequent pregnancies between the two groups (control and intervention).

The only identifier provided to SAIL from each of the 4 sources was the Study ID. SAIL assigned an anonymous linking field (ALF) to each individual to replace the study ID. The study ID-ALF key is encrypted and stored securely by SAIL. The individuals analysing the data will not have access to this key. The key was the same for each datasets so that all data could be linked without using identifiers to do so. The key is retained by SAIL to enable any individual who expresses at a later date a wish to be removed from the study to be removed from the database.

The research team work within the United Kingdom Clinical Research Collaboration (UKCRC) fully registered clinical trials unit - Centre for Trials Research at Cardiff University and at University College London (UCL). UCL researchers write and run analysis code on the dataset.

The Data will be accessed by authorised personnel via remote access. The Data will remain on servers at Cardiff University at all times.

Remote processing will only be through a secure electronic network. Technical and organisational controls prevent and prohibit personnel from downloading or copying data to local devices.

Remote processing will be subject to the following being in place:

- Multifactor authentication (MFA);

- Access controls granting users the minimum level of access required;

- Secure connections (e.g., VPNs or secure protocols) to protect data during remote access;

- Device security, including up-to-date software and operating systems, antivirus software, and enabled firewalls.

All remote access is undertaken within the scope of the relevant organisations’ DSPT (or other security arrangements as per this Data Sharing Agreement (DSA)).

Following analysis, aggregated results / publishable information could be requested from the secure environment for wider disclosure (subject to the data file being approved by data guardians at SAIL). Data guardians check for sensitive data, and small numbers that could risk disclosure before approving the file. All exports of data were approved by SAIL who ensure raw data and results with small numbers (and therefore a risk of identification) are not exported. Only derived data such as graphs, statistical analyses outputs and aggregated tables will be exported out of the secure portal. All staff who access the data have completed the MRC Safe researcher training which covers areas such as data protection and confidentiality.

Expected output

The results will be of relevance to many different audiences: policymakers at the Department for Education (DfE) and at Department for Health and Social Care (DHSC), and at Public Health England (PHE) in England; at the “National Centre on Early Prevention” (Nationales Zentrum Frühe Hilfen, NZFH), the Ministry for Social Affairs, Health, Women and Family in the German Republic of Saarland and the Federal Ministry of Family Affairs, Senior Citizens, Women and Youth in Germany; the National Health Service (NHS) in England; think tanks; local authorities; practitioners; advocacy groups; media and commentators; and the academic community across several disciplines, ranging from economics to psychology and child development.

The main academic project outputs will be at least two journal articles (one for each study analysis). For the two main publications the study team will target two top economics journals. Upon project completion and in adherence with the publication plan, the study team will consider submitting specific findings for publication in child development or public health journals, to facilitate dissemination to a wider audience. The publication of the report will be advertised through a press release, and the study team will also organize an end-of-project workshop, where academics, practitioners and representatives from FNP, DfE, DHSC, PHE and NHS will be invited to discuss the implications of the findings. To make sure this will reach out to the relevant policy circles, the study team will exploit the fact that the Principal investigator is a Trustee of the Foundation Years Information and Research Group. The Group devoted its yearly seminar series in 2016/2017 to the FNP, and visited the Ministry for Social Affairs, Health, Women and Family in the German Republic of Saarland to study their home visiting programmes in January 2018.

All access for analysis is to anonymised data.. No identifiable data will be accessed. Published results will only contain aggregated data with small numbers suppressed. All outputs will be aggregated with small numbers suppressed in line with the HES Analysis Guide.

Initial (main) academic outputs and secondary outputs were expected by Summer 2022. Most analyses have been completed but some remain. To allow for completion of the analysis, including the necessity to respond to peer review feedback on outputs, the study team wish to extend the DSA to October 2025.

Expected measurable benefits

It is expected that the analyses will inform the further development of the home visiting programmes in both the UK and in Germany, as well as being more generally informative for the programme developers in the US. To date, the Cardiff-led study of the programme has resulted in national level innovation and improvement in England (e.g. via the FNP ADAPT programme – the final report on this programme was published online in March 2020: https://www.fnp.nhs.uk/media/1359/fnp_adapt_report_web.pdf) with a consequent impact of improved services for families. The analysis aims to inform service development and is part of suite of similar activity being undertaken either led by Cardiff (e.g. in Scotland) and in association with Cardiff (e.g. in England). These two other studies (in Scotland and in England) are not using NHS data under the current DSA. This body of work will shed light on the extent to which (and how) early interventions are cost-effective in promoting health and reducing inequality.

The primary aim of this work is to build knowledge on what determines the effectiveness of home-visiting programmes targeting first-time teenage mothers in contexts with existing universal health care and extensive welfare provision. Understanding the mechanisms through which these interventions achieve their observed impacts is crucial for their long-term sustainability and cost-effectiveness of the programme both in England and Germany.

The FNP National Unit released the final report of the ambitious ADAPT (Accelerated Design And Programme Testing) project in 2020. This introduced and tested several adaptations of the programme following the publication of the original trial results in 2015. These additional analyses will provide new evidence to inform the future of the programme, which remains uncertain.

As part of the previous follow-on study (funded by NIHR PHR), Cardiff University met with DHSC and FNP National Unit to discuss the emerging results (which were first published in February 2021). This has influenced their decisions and recommendations made regarding funding for the FNP National Unit.

Preliminary outputs from the analysis has been shared in confidence with a stakeholder advisory group including leadership from the FNP team in England. This has been beneficial in informing ongoing analysis and interpretation, as well as providing early insights to policy in England about the nature of the new findings (which remain to be published).

Benefits reported so far

The original Building Blocks trial (BB:0-2) provided evidence for the short-term effectiveness of the programme (up to 2 years after birth). The Building Blocks: 2-6 (BB:2-6) study has now provided evidence for the medium-term effectiveness and costs of one of the most promising early intervention programmes for reducing risk of child maltreatment in a targeted vulnerable population. Both studies have provided evidence which has informed policy decision-making at both national and local level about whether to continue implementing the programme and also changes to programme content, format and delivery.

Datasets on the current version

Legal basis for provision: Health and Social Care Act 2012 – s261(2)(a)

Datasets approved under DARS-NIC-374907-Q5W5W-v3.2
DatasetType of dataSensitivity FrequencyConfidential data
Civil Registrations of Death - Secondary Care Cut Anonymised - ICO Code Compliant Sensitive One-Off Does not include the flow of confidential data
HES:Civil Registration (Deaths) bridge Anonymised - ICO Code Compliant Non-Sensitive One-Off Does not include the flow of confidential data
Hospital Episode Statistics Accident and Emergency (HES A and E) Anonymised - ICO Code Compliant Non-Sensitive One-Off Does not include the flow of confidential data
Hospital Episode Statistics Admitted Patient Care (HES APC) Anonymised - ICO Code Compliant Non-Sensitive One-Off Does not include the flow of confidential data
Hospital Episode Statistics Outpatients (HES OP) Anonymised - ICO Code Compliant Non-Sensitive One-Off Does not include the flow of confidential data

Files released

Files released counts only files released externally by DARS. Access granted in NHS England's own systems, such as its Secure Data Environment, is not included.

No files recorded as released under this agreement.

Version history

The register lists each renewal of this agreement as a separate row. This site has 4 versions.

DARS-NIC-374907-Q5W5W-v3.2 23 February 2026 to 22 February 2027
Title
Exploring the mechanisms through which specialist home visiting produces health and well-being benefits for families.
Commercial
No
Sublicensing
No
Datasets
5
Files released
0

Datasets: Civil Registrations of Death - Secondary Care Cut; HES:Civil Registration (Deaths) bridge; Hospital Episode Statistics Accident and Emergency (HES A and E); Hospital Episode Statistics Admitted Patient Care (HES APC); Hospital Episode Statistics Outpatients (HES OP)

What changed from DARS-NIC-374907-Q5W5W-v2.3

Text removed is struck through; text added is underlined. Unchanged paragraphs are summarised rather than repeated.

Fields changed from DARS-NIC-374907-Q5W5W-v2.3
FieldWasBecame
Start date2025-01-242026-02-23
End date2026-02-152027-02-22
Civil Registrations of Death - Secondary Care Cut: legal basisHealth and Social Care Act 2012 – s261(2)(b)(ii)Health and Social Care Act 2012 – s261(2)(a)
HES:Civil Registration (Deaths) bridge: legal basisHealth and Social Care Act 2012 – s261(2)(b)(ii)Health and Social Care Act 2012 – s261(2)(a)
Hospital Episode Statistics Accident and Emergency (HES A and E): legal basisHealth and Social Care Act 2012 – s261(2)(b)(ii)Health and Social Care Act 2012 – s261(2)(a)
Hospital Episode Statistics Admitted Patient Care (HES APC): legal basisHealth and Social Care Act 2012 – s261(2)(b)(ii)Health and Social Care Act 2012 – s261(2)(a)
Hospital Episode Statistics Outpatients (HES OP): legal basisHealth and Social Care Act 2012 – s261(2)(b)(ii)Health and Social Care Act 2012 – s261(2)(a)

Unchanged: Objective for processing, Processing activities, Expected output, Expected measurable benefits, Benefits reported.

DARS-NIC-374907-Q5W5W-v2.3 24 January 2025 to 15 February 2026
Title
Exploring the mechanisms through which specialist home visiting produces health and well-being benefits for families.
Commercial
No
Sublicensing
No
Datasets
5
Files released
0

Datasets: Civil Registrations of Death - Secondary Care Cut; HES:Civil Registration (Deaths) bridge; Hospital Episode Statistics Accident and Emergency (HES A and E); Hospital Episode Statistics Admitted Patient Care (HES APC); Hospital Episode Statistics Outpatients (HES OP)

What changed from DARS-NIC-374907-Q5W5W-v1.6

Text removed is struck through; text added is underlined. Unchanged paragraphs are summarised rather than repeated.

Fields changed from DARS-NIC-374907-Q5W5W-v1.6
FieldWasBecame
Start date2024-02-162025-01-24
End date2025-02-152026-02-15

Benefits reported

[1 paragraph unchanged] The study team may be in a position to report further yielded benefits following completion of the analysis when main, and secondary outputs have been published and peer reviewed.

Unchanged: Objective for processing, Processing activities, Expected output, Expected measurable benefits.

Objective for processing

BACKGROUND

(i) Specialist home visiting to support new families:

The Family Nurse Partnership (FNP) was developed and licensed by the University of Colorado as a voluntary, preventive programme for vulnerable young first time mothers. It offers intensive and structured home visiting, delivered by specially trained nurses, from early pregnancy until age two. The three aims are: to improve pregnancy outcomes, improve child health and development and improve parents’ economic self-sufficiency.

A strong and rigorous US evidence base, developed over 30 years, has shown FNP benefits the neediest young families in the short, medium, and long term across a wide range of outcomes helping improve social mobility and break the cycle of inter-generational disadvantage and poverty.

(ii) Work to establish the programme in the UK and the Cardiff evaluations:

The programme was adapted for implementation and introduced in England in 2007. Due to the greatly differing nature of publicly funded health and social care service provision and socio-cultural context between England and the US, the relative benefits of the programme need to be replicated in England and costs determined before wide-spread implementation can be recommended. The study team have conducted two definitive evaluations:

BB:0-2 - Department of Health and Social Care (DHSC) commissioned the ‘Building Blocks’ randomised controlled trial (RCT) from Cardiff University to provide independent evidence on the effectiveness of the FNP programme in improving short term outcomes for young parents and their babies. The trial began in 2009 and the findings which cover the period from pregnancy to the child’s second birthday' were published in October 2015. The FNP described these as “important early findings and add to the evidence the study team have from the US, Netherlands and other early evaluation in England to help improve FNP in England.”

BB: 2-6 - The National Institute of Health Research further funded Cardiff University to undertake a follow up study to examine child and maternal outcomes to age six. This built on the original study to examine the longer-term impact of FNP intervention. Its principal objective was to determine the effectiveness of the FNP programme in reducing objectively measured long-term maltreatment outcomes when compared to usually provided health and social care alone. The main research outcomes were child in need status, child protection registration, referral to social care. Other indicators of programme impact included measures of injuries and ingestions and hospital DNA rates. The study report has been externally peer reviewed and was published by NIHR in February 2021: https://www.journalslibrary.nihr.ac.uk/phr/phr09020/#/full-report.

The main journal article is published here: https://bmjopen.bmj.com/content/bmjopen/12/2/e049960.full.pdf

In the BB:2-6 study, Cardiff University followed-up the cohort of mothers and children who took part in the first Building Blocks trial (BB:0-2) by obtaining health and mortality data from NHS England, data from Department for Education (DfE) and data from the Department of Health (abortion statistics) and linked with the original trial data.

(iii) Evidence from the Cardiff work and NHS England supplied data to date

The original Building Blocks trial (BB:0-2) provided evidence for the short-term effectiveness of the programme (up to 2 years after birth). The Building Blocks: 2-6 (BB:2-6) study has now provided evidence for the medium-term effectiveness and costs of one of the most promising early intervention programmes for reducing risk of child maltreatment in a targeted vulnerable population. Specifically, data requested from NHS England provided the basis for key study outcomes which are indicators of maltreatment. Both studies have provided evidence which has informed policy decision-making at both national and local level about whether to continue implementing the programme and also changes to programme content, format and delivery.

OBJECTIVES OF THIS STUDY

In 2019/20, the study team received additional funding to analyse pseudonymised study data already held in the data safe haven (which includes NHS England supplied data provided under DARS-NIC-333498-D1K7G). These analyses explore the mechanisms by which specialist home visiting may have its effect for recipient families. Two funders (Nuffield Foundation, European Research Council (ERC)) provided resources to support the two separate analyses both of which utilise the same existing data set.

Proposed analyses funded by ERC and Nuffield Trust:

The analyses explore the mechanisms by which specialist home visiting may have its effect for recipient families. The analyses to date have determined the impact of the home visiting intervention upon a wide range of family outcomes. These range from the antenatal period through to early in children’s school life (i.e. at key stage 1). The study team explored how home visiting has benefited some families but has been less effective for others. The study team also assessed the additional benefit that receiving more home visits has had for some of the more important outcomes that have been assessed. The study team explored the perceptions of both mothers and family nurses (i.e. the professionals who deliver home visits to families) about how the home visiting may exert its effect (and what may be a barrier to its effectiveness). The study team explored how some outcomes (such as children being designated as In Need by local departments of children’s services) are influenced by a range of potential risk factors (for example, attributes of the mother and child).

The analysis takes an econometric approach to explore how the benefits of the home visiting intervention are produced. The study explores the mechanisms through which the home visiting intervention is hypothesised to produce benefits (for example, whether expected changes in maternal behaviour occur and whether these then lead to other improvements). The study explores how characteristics of nurses plays any part in observed effects (for example, whether some nurses are associated with more or less improvement. This may be due to differences in clinical experience or training, for example). It explores further how home visiting dose and quality may be linked to differential family benefits (visit-level data available for each mother in receipt of specialist home-visiting provides detail on how many visits were delivered, their duration and the content addressed using the scheme’s standard monitoring form). Finally, the study assesses how reported use of other public sector services may also have an influence. The existing trial cohort data (including Data provided by NHS England) has been analysed using state-of-the-art economics methods, benefiting from the input of the lead investigator who secured the additional funding. The analysis dynamically models the study data to establish more clearly than has been possible previously how the home visiting programme produces benefits for families.

The two analyses (Nuffield and ERC) use an existing pseudonymised data set supplied by NHS England under DARS-NIC-333498-D1K7G-v4.4. The first (Nuffield), involves two similar study cohorts being assessed in the new analyses (the other being from a study in Germany which implemented a similar intervention). The analyses for the two cohorts run in parallel (i.e. the data will remain where currently located) but similar research questions were asked of the two study datasets. NHS England Data held by Cardiff as data controller will not be shared or linked to the German data. Only derived outputs are compared when interpreting the outputs from the two analyses. The second funded analysis (ERC) involves a broader range of data drawn from a variety of sources these include: distance from / price of / availability of goods and services for children (e.g. price of toys, distance from GP/parks, food prices); and prices of cigarettes, alcohol and local wages. Like the Nuffield funded work, the ERC analyses involve data from the Building Blocks trial cohort being analysed separately from any other project data but will share a common underlying research question and specialist economics methods. For the analysis of the Building Blocks dataset more detailed exploration of (non-NHS) trial data based on existing post code is used to determine the role of local context (including policies) upon family outcomes, no attempt will made to identify or link the data.

The two project grants are led by a member of staff at UCL and the analyses is undertaken by the research fellow and themselves, both of whom are substantive employees of UCL. Access to the Data is approved by the study lead at Cardiff University. All analyses is reviewed and approved by the study lead at Cardiff University. This study lead is the chief investigator and is costed into both grants to provide these approvals and oversee all outputs from the study. A statistician based in Cardiff and approved to access the cohort dataset has responsibility to review the statistical analysis plan for both Nuffield and ERC-funded studies.

Cardiff University was the Controller (and sponsor) of the original study and Swansea University (and Cardiff University) were Processors, however Swansea are no-longer involved in any capacity. This agreement includes UCL as a joint controller who processes data. UCL make decisions on the manner of data processing, and the two project grants are led by a member of staff from UCL. The additional funded work is funded by both the European Research Council and Nuffield Trust. Neither body may make decisions related to how the data are processed and will not have access to the data. The Chair of the Information Governance Review Panel at SAIL (Swansea University) confirmed that as the data being accessed in relation to the study are appropriately anonymised, no further ethical review was required.

The UK GDPR legal basis for processing NHS England data are: Article 6:1(e):This project is a task in the public interest because it was commissioned by the Department of Health to evaluate the impact of home-visiting interventions on child maltreatment; and, Article 9:2(j):This is scientific research which uses only the data required to answer these important research aims, using a data safe haven to protect the data and outputs this research will directly influence policy making regarding home visiting programmes to benefit the UK public.

DATA SUBJECTS

The cohort consists of 1645 women (and their first-born child(ren)) who met eligibility criteria for participation in the Building Blocks trial of the Family Nurse Partnership (FNP) and were nulliparous (a woman who has never given birth either by choice or for any other reason. This term also applies to women who have given birth to a stillborn baby, or a baby who was otherwise not able to survive outside the womb) women aged 19 or under, living in one of 18 local authority FNP catchment areas in England who were recruited by 24+6 weeks gestation, had conversational level of English and were able to consent to research.

Women were recruited by locally-based research professionals usually employed by local NHS organisations following identification through NHS maternity units. Women provided their written informed consent to participate including for data in their administrative health records to be provided to the research team.

Relevant Data for the study cohort provided by NHS England under DARS-NIC-333498-D1K7G-v4.4 include: Civil Registrations of Death; Hospital Episode Statistics A&E; Outpatients; and, Admitted Patient Care. These data were used to follow-up mothers recruited into the study and their babies, up until the baby’s second birthday. These datasets are the main source of data for two of the primary outcomes (and several secondary outcomes).

The BB:0-2 trial began in 2009 and the findings which cover the period from pregnancy to the child’s second birthday' were published in October 2015 and available here: https://doi.org/10.1016/S0140-6736(15)00392-X

The National Institute of Health Research funded BB:2-6 study follow up study examined child outcomes to age six, building on the original study examining the longer term impact of FNP intervention. A subsequent application for data from NHS England (DARS-NIC-333498-D1K7G) permitted collection of the same health data for an additional four years, until the mother’s first child(ren) was aged six years old. As identifiable data were required to enable linkage of the original trial cohort data to these new records, section 251 approval was given.

The Building Blocks study originally involved a lay group who advised on aspects of trial delivery and provided input into the design and setup of the study. An independent group of young people also provided advice to the research team and a lay perspective on the general management and delivery of the project and in particular the preparation of the outputs from the study.

Expected output

The results will be of relevance to many different audiences: policymakers at the Department for Education (DfE) and at Department for Health and Social Care (DHSC), and at Public Health England (PHE) in England; at the “National Centre on Early Prevention” (Nationales Zentrum Frühe Hilfen, NZFH), the Ministry for Social Affairs, Health, Women and Family in the German Republic of Saarland and the Federal Ministry of Family Affairs, Senior Citizens, Women and Youth in Germany; the National Health Service (NHS) in England; think tanks; local authorities; practitioners; advocacy groups; media and commentators; and the academic community across several disciplines, ranging from economics to psychology and child development.

The main academic project outputs will be at least two journal articles (one for each study analysis). For the two main publications the study team will target two top economics journals. Upon project completion and in adherence with the publication plan, the study team will consider submitting specific findings for publication in child development or public health journals, to facilitate dissemination to a wider audience. The publication of the report will be advertised through a press release, and the study team will also organize an end-of-project workshop, where academics, practitioners and representatives from FNP, DfE, DHSC, PHE and NHS will be invited to discuss the implications of the findings. To make sure this will reach out to the relevant policy circles, the study team will exploit the fact that the Principal investigator is a Trustee of the Foundation Years Information and Research Group. The Group devoted its yearly seminar series in 2016/2017 to the FNP, and visited the Ministry for Social Affairs, Health, Women and Family in the German Republic of Saarland to study their home visiting programmes in January 2018.

All access for analysis is to anonymised data.. No identifiable data will be accessed. Published results will only contain aggregated data with small numbers suppressed. All outputs will be aggregated with small numbers suppressed in line with the HES Analysis Guide.

Initial (main) academic outputs and secondary outputs were expected by Summer 2022. Most analyses have been completed but some remain. To allow for completion of the analysis, including the necessity to respond to peer review feedback on outputs, the study team wish to extend the DSA to October 2025.

Benefits reported

The original Building Blocks trial (BB:0-2) provided evidence for the short-term effectiveness of the programme (up to 2 years after birth). The Building Blocks: 2-6 (BB:2-6) study has now provided evidence for the medium-term effectiveness and costs of one of the most promising early intervention programmes for reducing risk of child maltreatment in a targeted vulnerable population. Both studies have provided evidence which has informed policy decision-making at both national and local level about whether to continue implementing the programme and also changes to programme content, format and delivery.

DARS-NIC-374907-Q5W5W-v1.6 16 February 2024 to 15 February 2025
Title
Exploring the mechanisms through which specialist home visiting produces health and well-being benefits for families.
Commercial
No
Sublicensing
No
Datasets
5
Files released
0

Datasets: Civil Registrations of Death - Secondary Care Cut; HES:Civil Registration (Deaths) bridge; Hospital Episode Statistics Accident and Emergency (HES A and E); Hospital Episode Statistics Admitted Patient Care (HES APC); Hospital Episode Statistics Outpatients (HES OP)

What changed from DARS-NIC-374907-Q5W5W-v0.6

Text removed is struck through; text added is underlined. Unchanged paragraphs are summarised rather than repeated.

Fields changed from DARS-NIC-374907-Q5W5W-v0.6
FieldWasBecame
Start date2020-11-012024-02-16
End date2023-10-312025-02-15

Objective for processing

BACKGROUND [6 paragraphs unchanged] BB: 2-6 - The National Institute of Health Research further funded Cardiff [87 words unchanged] hospital DNA rates. The study report has been externally peer reviewed and a final version will be was published by NIHR in November 2020. February 2021: https://www.journalslibrary.nihr.ac.uk/phr/phr09020/#/full-report. In the BB:2-6 study, Cardiff University followed-up the cohort of mothers and children who took part in the first Building Blocks trial (BB:0-2) by obtaining health and mortality data from NHS Digital, data from Department for Education (DfE) and data from the Department of Health (abortion statistics) and linked with the original trial data. The main journal article is published here: https://bmjopen.bmj.com/content/bmjopen/12/2/e049960.full.pdf (iii) Evidence from the Cardiff work and NHS Digital supplied data to date In the BB:2-6 study, Cardiff University followed-up the cohort of mothers and children who took part in the first Building Blocks trial (BB:0-2) by obtaining health and mortality data from NHS England, data from Department for Education (DfE) and data from the Department of Health (abortion statistics) and linked with the original trial data. The original Building Blocks trial (BB:0-2) provided evidence for the short-term effectiveness of the programme (up to 2 years after birth). The Building Blocks: 2-6 (BB:2-6) study has now provided evidence for the medium-term effectiveness and costs of one of the most promising early intervention programmes for reducing risk of child maltreatment in a targeted vulnerable population. Specifically, data requested from NHS Digital provided the basis for key study outcomes which are indicators of maltreatment. Both studies have provided evidence which has informed policy decision-making at both national and local level about whether to continue implementing the programme and also changes to programme content, format and delivery. (iii) Evidence from the Cardiff work and NHS England supplied data to date (iv) Newly funded work 2019/20: The original Building Blocks trial (BB:0-2) provided evidence for the short-term effectiveness of the programme (up to 2 years after birth). The Building Blocks: 2-6 (BB:2-6) study has now provided evidence for the medium-term effectiveness and costs of one of the most promising early intervention programmes for reducing risk of child maltreatment in a targeted vulnerable population. Specifically, data requested from NHS England provided the basis for key study outcomes which are indicators of maltreatment. Both studies have provided evidence which has informed policy decision-making at both national and local level about whether to continue implementing the programme and also changes to programme content, format and delivery. This new request reflects the receipt of additional funding to analyse the existing pseudonymised study data already held in the data safe haven (which includes NHS Digital supplied data). The newly funded analyses will explore the mechanisms by which specialist home visiting may have its effect for recipient families. Two funders (Nuffield Foundation, European Research Council (ERC)) have provided resource to support the two separate analyses both of which will utilise the same existing data set. OBJECTIVES OF THIS STUDY In 2019/20, the study team received additional funding to analyse pseudonymised study data already held in the data safe haven (which includes NHS England supplied data provided under DARS-NIC-333498-D1K7G). These analyses explore the mechanisms by which specialist home visiting may have its effect for recipient families. Two funders (Nuffield Foundation, European Research Council (ERC)) provided resources to support the two separate analyses both of which utilise the same existing data set. [1 paragraph unchanged] The newly funded analyses will explore the mechanisms by which specialist home visiting may have its effect [32 words unchanged] in children’s school life (i.e. at key stage 1). The study team have explored how home visiting has benefited some families but has been less effective for others. The study team have also assessed the additional benefit that receiving more home visits has had for some of the more important outcomes that have been assessed. The study team have explored the perceptions of both mothers and family nurses (i.e. the professionals [15 words unchanged] (and what may be a barrier to its effectiveness). The study team have explored how some outcomes (such as children being designated as In Need [11 words unchanged] of potential risk factors (for example, attributes of the mother and child). The new analysis will take takes an econometric approach to explore how the benefits of the home visiting intervention are produced. It will explore The study explores the mechanisms through which the home visiting intervention is hypothesised to produce [6 words unchanged] in maternal behaviour occur and whether these then lead to other improvements). It will explore The study explores how characteristics of nurses plays any part in observed effects (for example, [12 words unchanged] be due to differences in clinical experience or training, for example). It will explore explores further how home visiting dose and quality may be linked to differential [22 words unchanged] duration and the content addressed using the scheme’s standard monitoring form). Finally, it will also assess the study assesses how reported use of other public sector services may also have an influence. The existing trial cohort data (including that derived from the Data provided by NHS via NHS Digital) will be England) has been analysed using state-of-the-art economics methods, benefiting from the input of the lead investigator who has secured the additional funding. The analysis will be able to model dynamically models the study data to establish more clearly than has been possible previously how the home visiting programme produces benefits for families. These The two analyses (Nuffield and ERC) will both use the an existing pseudonymised data set. set supplied by NHS England under DARS-NIC-333498-D1K7G-v4.4. The first (Nuffield), will involve involves two similar study cohorts being assessed in the new analyses (the other [5 words unchanged] Germany which implemented a similar intervention). The analyses for the two cohorts will be run in parallel (i.e. the data will remain where currently located) but similar research questions will be were asked of the two study datasets. No UK data currently NHS England Data held by Cardiff as data controller will not be shared or linked to the German data. Only results will be derived outputs are compared when interpreting the outputs from the two analyses. The second funded analysis (ERC), will involve (ERC) involves a broader range of data drawn from a variety of sources these will include: distance from / price of / availability of goods and services [15 words unchanged] alcohol and local wages. Like the Nuffield funded work, the ERC analyses will involve data from the Building Blocks trial cohort being analysed separately from [24 words unchanged] more detailed exploration of (non-NHS) trial data based on existing post code will be is used to determine the role of local context (including policies) upon family outcomes, no attempt will made to identify or link the data. The two new project grants are led by a member of staff at UCL and the analyses will be is undertaken by the research fellow and themselves, both of whom are substantive employees of UCL and hold honorary titles with Cardiff University for UCL. Access to the duration of the studies. Access will be as described above, and access will be Data is approved by the study lead at Cardiff University. All analyses will be is reviewed and approved by the study lead at Cardiff University. This study [9 words unchanged] both grants to provide these approvals and oversee all outputs from the additionally funded work. study. A statistician based in Cardiff and currently approved to access the cohort dataset will have has responsibility to review the statistical analysis plan for both Nuffield and ERC-funded studies. Cardiff University was the Data Controller (and sponsor) of the original study and Swansea University (and Cardiff University) were Data Processors. Processors, however Swansea are no-longer involved in any capacity. This new application will also include agreement includes UCL as a joint controller who processes data. UCL make decisions on the manner of data processing, and processor. the two project grants are led by a member of staff from UCL. The additional funded work is funded by both the European Research Council [21 words unchanged] the data. The Chair of the Information Governance Review Panel at SAIL has (Swansea University) confirmed that as the data being accessed in relation to the newly funded work study are appropriately anonymised, no further ethical review is was required. Cardiff University The UK GDPR legal basis for processing NHS England data are: Article 6:1(e):This project is a task in the public interest because it was commissioned by the Department of Health to evaluate the impact of home-visiting interventions on child maltreatment; and, Article 9:2(j):This is scientific research which uses only the data required to answer these important research aims, using a data safe haven to protect the data and outputs this research will directly influence policy making regarding home visiting programmes to benefit the UK public. Article 6:1(e):This project is a task in the public interest because it was commissioned by the Department of Health to evaluate the impact of home-visiting interventions on child maltreatment. DATA SUBJECTS Article 9:2(j):This is scientific research which uses only the data required to answer these important research aims, using a data safe haven to protect the data and outputs this research will directly influence policy making regarding home visiting programmes to benefit the UK public. The cohort consists of 1645 women (and their first-born child(ren)) who met eligibility criteria for participation in the Building Blocks trial of the Family Nurse Partnership (FNP) and were nulliparous (a woman who has never given birth either by choice or for any other reason. This term also applies to women who have given birth to a stillborn baby, or a baby who was otherwise not able to survive outside the womb) women aged 19 or under, living in one of 18 local authority FNP catchment areas in England who were recruited by 24+6 weeks gestation, had conversational level of English and were able to consent to research. University College London Article 6(1)(e) of the General Data Protection Regulations (GDPR), i.e. “a task carried out in the public interest”. It also falls under Article 9(2)(j), “processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes”. (v) Clarification about data subjects The data subjects were 1645 women (and their first-born child(ren)) who met eligibility criteria for participation in the Building Blocks trial of the Family Nurse Partnership (FNP) and were nulliparous (a woman who has never given birth either by choice or for any other reason. This term also applies to women who have given birth to a stillborn baby, or a baby who was otherwise not able to survive outside the womb) women aged 19 or under, living in one of 18 local authority FNP catchment areas in England who were recruited by 24+6 weeks gestation, had conversational level of English and were able to consent to research. [1 paragraph unchanged] Relevant Data for the study cohort data provided for trial by NHS Digital England under DARS-NIC-333498-D1K7G-v4.4 include: Civil Registrations of Death; Hospital Episode Statistics A&E; Outpatients; and, Admitted Patient Care. These data were Inpatient, Outpatient, A&E datasets and used to follow-up mothers recruited into the study and their babies, up until the baby’s second birthday. These datasets were are the main source of data for two of the primary outcomes (and several secondary outcomes). The BB:0-2 trial began in 2009 and the findings which cover the period from pregnancy to the child’s second birthday' were published in October 2015. 2015 and available here: https://doi.org/10.1016/S0140-6736(15)00392-X The National Institute of Health Research funded BB:2-6 study follow up study [14 words unchanged] term impact of FNP intervention. A subsequent application for data from NHS Digital England (DARS-NIC-333498-D1K7G) permitted collection of the same health data for an additional four [22 words unchanged] trial cohort data to these new records, section 251 approval was given. [1 paragraph unchanged]

Processing activities

All data transfers have now concluded and data now would only be analysed in the data safe haven, there is no requirement and there will be no attempt to reidentify the individuals in the cohort. Any reference to data flows are now historic. Data already supplied by NHS Digital are described under Products for clarity (having been previously supplied under agreement DARS-NIC-333498-D1K7G-v4. All data transfers have concluded and there are no further flows of data. Historically, the Data was analysed in the SAIL data safe haven at Swansea University. The NHSE Data was securely transferred from Swansea University to Cardiff University on 09/02/2024. Swansea are no-longer involved in any capacity. Cardiff University provided the following fields to NHS Digital: There is no requirement and there will be no attempt to reidentify the individuals in the cohort. Data already supplied by NHS England under DARS-NIC-333498-D1K7G-v4 are described in the Products section of this Agreement for clarity. Cardiff University provided the following fields to NHS England under DARS-NIC-333498-D1K7G-v4 to enable tracing of the cohort : [5 paragraphs unchanged] Under agreement DARS-NIC-333498-D1K7G-v4, NHS Digital England linked this information to the HES and mortality data, stripped out the [100 words unchanged] the rates of subsequent pregnancies between the two groups (control and intervention). [1 paragraph unchanged] The research team work within the United Kingdom Clinical Research Collaboration (UKCRC) [7 words unchanged] for Trials Research at Cardiff University and at University College London (UCL). UCL researchers write and run analysis code on the dataset. Mitigating risks of re-identification: All data will be maintained in the safe data haven in Swansea [SAIL] within which all analyses will be undertaken. The research database will not be made available to other researchers (this will be a project specific resource). Access to the pseudonymised dataset will be via a secure remote portal. No data will leave the secure environment at SAIL. Approved, named data users can access the portal and defined data views remotely, subject to the appropriate access level being set and secure access keys being provided to them. Data cannot be downloaded from the portal; all exports of data are approved by SAIL who ensure raw data and results with small numbers (and therefore a risk of identification) are not exported. Only graphs, statistical analyses outputs and aggregated tables will be exported out of the secure portal. All staff who access the data have completed the MRC Safe researcher training which covers areas such as data protection and confidentiality. The Data will be accessed by authorised personnel via remote access. The Data will remain on servers at Cardiff University at all times. Following analysis, aggregated results / publishable information can be requested out of the secure environment for wider disclosure (subject to the data file being approved by data guardians at SAIL). Data guardians check for sensitive data, and small numbers that could risk disclosure before approving the file. Remote processing will only be through a secure electronic network. Technical and organisational controls prevent and prohibit personnel from downloading or copying data to local devices. Both organisations party to this agreement must comply with Data Sharing Framework Contract requirements at their respective organisations, including those regarding the use (and purposes of that use) by “Personnel” (as defined within the Data Sharing Framework Contract i.e.: employees, agents and contractors of the Data Recipient who may have access to that data). The members of staff holding the honorary title with Cardiff University will be contractually bound to the data sharing agreement between UCL and Cardiff University. This contract refers to both the Framework and project-level Data sharing agreement as well as the User agreement with SAIL which covers disclosure requirements. Remote processing will be subject to the following being in place: - Multifactor authentication (MFA); - Access controls granting users the minimum level of access required; - Secure connections (e.g., VPNs or secure protocols) to protect data during remote access; - Device security, including up-to-date software and operating systems, antivirus software, and enabled firewalls. All remote access is undertaken within the scope of the relevant organisations’ DSPT (or other security arrangements as per this Data Sharing Agreement (DSA)). Following analysis, aggregated results / publishable information could be requested from the secure environment for wider disclosure (subject to the data file being approved by data guardians at SAIL). Data guardians check for sensitive data, and small numbers that could risk disclosure before approving the file. All exports of data were approved by SAIL who ensure raw data and results with small numbers (and therefore a risk of identification) are not exported. Only derived data such as graphs, statistical analyses outputs and aggregated tables will be exported out of the secure portal. All staff who access the data have completed the MRC Safe researcher training which covers areas such as data protection and confidentiality.

Expected output

[2 paragraphs unchanged] All access for analysis is to pseudonymised data, no anonymised data.. No identifiable data will be accessed. Published results will only contain aggregated data [8 words unchanged] aggregated with small numbers suppressed in line with the HES Analysis Guide. Initial (main) academic outputs will be expected to be available by end 2021. Secondary outputs will be available by Summer 2022. Initial (main) academic outputs and secondary outputs were expected by Summer 2022. Most analyses have been completed but some remain. To allow for completion of the analysis, including the necessity to respond to peer review feedback on outputs, the study team wish to extend the DSA to October 2025.

Expected measurable benefits

It is expected that the new analyses will inform the further development of the home visiting programmes in [44 words unchanged] – the final report on this programme was published online in March 2020) 2020: https://www.fnp.nhs.uk/media/1359/fnp_adapt_report_web.pdf) with a consequent impact of improved services for families. The newly planned analyses will aim analysis aims to similarly lead to inform service development and is part of suite of similar activity being undertaken either led by Cardiff (e.g. in Scotland) and in association with Cardiff (e.g. in England). These two other studies (in Scotland and in England) although which are out with this specific not using NHS data under the current DSA. This body of work will shed light on the extent to which (and how) early interventions are cost-effective in promoting health and reducing inequality. The primary aim of this new work is to build knowledge on what determines the effectiveness of home-visiting [31 words unchanged] long-term sustainability and cost-effectiveness of the programme both in England and Germany. The FNP National Unit recently released the final report of the ambitious ADAPT (Accelerated Design And Programme Testing) project, which project in 2020. This introduced and tested several adaptations of the programme following the publication of the original trial results. results in 2015. These additional analyses will provide timely new evidence to inform the future of the programme, which is remains uncertain. From As part of the study team’s previous follow-on study (funded by NIHR PHR) PHR), Cardiff University have been meeting met with DHSC and FNP National Unit to discuss the emerging results (which will be were first published later in 2020. February 2021). This has influenced their decisions and recommendations made regarding funding for the FNP National Unit which remain confidential at this stage. Unit. Preliminary outputs from the analysis has been shared in confidence with a stakeholder advisory group including leadership from the FNP team in England. This has been beneficial in informing ongoing analysis and interpretation, as well as providing early insights to policy in England about the nature of the new findings (which remain to be published).

Benefits reported

[1 paragraph unchanged] The study team may be in a position to report further yielded benefits following completion of the analysis when main, and secondary outputs have been published and peer reviewed.

Objective for processing

BACKGROUND

(i) Specialist home visiting to support new families:

The Family Nurse Partnership (FNP) was developed and licensed by the University of Colorado as a voluntary, preventive programme for vulnerable young first time mothers. It offers intensive and structured home visiting, delivered by specially trained nurses, from early pregnancy until age two. The three aims are: to improve pregnancy outcomes, improve child health and development and improve parents’ economic self-sufficiency.

A strong and rigorous US evidence base, developed over 30 years, has shown FNP benefits the neediest young families in the short, medium, and long term across a wide range of outcomes helping improve social mobility and break the cycle of inter-generational disadvantage and poverty.

(ii) Work to establish the programme in the UK and the Cardiff evaluations:

The programme was adapted for implementation and introduced in England in 2007. Due to the greatly differing nature of publicly funded health and social care service provision and socio-cultural context between England and the US, the relative benefits of the programme need to be replicated in England and costs determined before wide-spread implementation can be recommended. The study team have conducted two definitive evaluations:

BB:0-2 - Department of Health and Social Care (DHSC) commissioned the ‘Building Blocks’ randomised controlled trial (RCT) from Cardiff University to provide independent evidence on the effectiveness of the FNP programme in improving short term outcomes for young parents and their babies. The trial began in 2009 and the findings which cover the period from pregnancy to the child’s second birthday' were published in October 2015. The FNP described these as “important early findings and add to the evidence the study team have from the US, Netherlands and other early evaluation in England to help improve FNP in England.”

BB: 2-6 - The National Institute of Health Research further funded Cardiff University to undertake a follow up study to examine child and maternal outcomes to age six. This built on the original study to examine the longer-term impact of FNP intervention. Its principal objective was to determine the effectiveness of the FNP programme in reducing objectively measured long-term maltreatment outcomes when compared to usually provided health and social care alone. The main research outcomes were child in need status, child protection registration, referral to social care. Other indicators of programme impact included measures of injuries and ingestions and hospital DNA rates. The study report has been externally peer reviewed and was published by NIHR in February 2021: https://www.journalslibrary.nihr.ac.uk/phr/phr09020/#/full-report.

The main journal article is published here: https://bmjopen.bmj.com/content/bmjopen/12/2/e049960.full.pdf

In the BB:2-6 study, Cardiff University followed-up the cohort of mothers and children who took part in the first Building Blocks trial (BB:0-2) by obtaining health and mortality data from NHS England, data from Department for Education (DfE) and data from the Department of Health (abortion statistics) and linked with the original trial data.

(iii) Evidence from the Cardiff work and NHS England supplied data to date

The original Building Blocks trial (BB:0-2) provided evidence for the short-term effectiveness of the programme (up to 2 years after birth). The Building Blocks: 2-6 (BB:2-6) study has now provided evidence for the medium-term effectiveness and costs of one of the most promising early intervention programmes for reducing risk of child maltreatment in a targeted vulnerable population. Specifically, data requested from NHS England provided the basis for key study outcomes which are indicators of maltreatment. Both studies have provided evidence which has informed policy decision-making at both national and local level about whether to continue implementing the programme and also changes to programme content, format and delivery.

OBJECTIVES OF THIS STUDY

In 2019/20, the study team received additional funding to analyse pseudonymised study data already held in the data safe haven (which includes NHS England supplied data provided under DARS-NIC-333498-D1K7G). These analyses explore the mechanisms by which specialist home visiting may have its effect for recipient families. Two funders (Nuffield Foundation, European Research Council (ERC)) provided resources to support the two separate analyses both of which utilise the same existing data set.

Proposed analyses funded by ERC and Nuffield Trust:

The analyses explore the mechanisms by which specialist home visiting may have its effect for recipient families. The analyses to date have determined the impact of the home visiting intervention upon a wide range of family outcomes. These range from the antenatal period through to early in children’s school life (i.e. at key stage 1). The study team explored how home visiting has benefited some families but has been less effective for others. The study team also assessed the additional benefit that receiving more home visits has had for some of the more important outcomes that have been assessed. The study team explored the perceptions of both mothers and family nurses (i.e. the professionals who deliver home visits to families) about how the home visiting may exert its effect (and what may be a barrier to its effectiveness). The study team explored how some outcomes (such as children being designated as In Need by local departments of children’s services) are influenced by a range of potential risk factors (for example, attributes of the mother and child).

The analysis takes an econometric approach to explore how the benefits of the home visiting intervention are produced. The study explores the mechanisms through which the home visiting intervention is hypothesised to produce benefits (for example, whether expected changes in maternal behaviour occur and whether these then lead to other improvements). The study explores how characteristics of nurses plays any part in observed effects (for example, whether some nurses are associated with more or less improvement. This may be due to differences in clinical experience or training, for example). It explores further how home visiting dose and quality may be linked to differential family benefits (visit-level data available for each mother in receipt of specialist home-visiting provides detail on how many visits were delivered, their duration and the content addressed using the scheme’s standard monitoring form). Finally, the study assesses how reported use of other public sector services may also have an influence. The existing trial cohort data (including Data provided by NHS England) has been analysed using state-of-the-art economics methods, benefiting from the input of the lead investigator who secured the additional funding. The analysis dynamically models the study data to establish more clearly than has been possible previously how the home visiting programme produces benefits for families.

The two analyses (Nuffield and ERC) use an existing pseudonymised data set supplied by NHS England under DARS-NIC-333498-D1K7G-v4.4. The first (Nuffield), involves two similar study cohorts being assessed in the new analyses (the other being from a study in Germany which implemented a similar intervention). The analyses for the two cohorts run in parallel (i.e. the data will remain where currently located) but similar research questions were asked of the two study datasets. NHS England Data held by Cardiff as data controller will not be shared or linked to the German data. Only derived outputs are compared when interpreting the outputs from the two analyses. The second funded analysis (ERC) involves a broader range of data drawn from a variety of sources these include: distance from / price of / availability of goods and services for children (e.g. price of toys, distance from GP/parks, food prices); and prices of cigarettes, alcohol and local wages. Like the Nuffield funded work, the ERC analyses involve data from the Building Blocks trial cohort being analysed separately from any other project data but will share a common underlying research question and specialist economics methods. For the analysis of the Building Blocks dataset more detailed exploration of (non-NHS) trial data based on existing post code is used to determine the role of local context (including policies) upon family outcomes, no attempt will made to identify or link the data.

The two project grants are led by a member of staff at UCL and the analyses is undertaken by the research fellow and themselves, both of whom are substantive employees of UCL. Access to the Data is approved by the study lead at Cardiff University. All analyses is reviewed and approved by the study lead at Cardiff University. This study lead is the chief investigator and is costed into both grants to provide these approvals and oversee all outputs from the study. A statistician based in Cardiff and approved to access the cohort dataset has responsibility to review the statistical analysis plan for both Nuffield and ERC-funded studies.

Cardiff University was the Controller (and sponsor) of the original study and Swansea University (and Cardiff University) were Processors, however Swansea are no-longer involved in any capacity. This agreement includes UCL as a joint controller who processes data. UCL make decisions on the manner of data processing, and the two project grants are led by a member of staff from UCL. The additional funded work is funded by both the European Research Council and Nuffield Trust. Neither body may make decisions related to how the data are processed and will not have access to the data. The Chair of the Information Governance Review Panel at SAIL (Swansea University) confirmed that as the data being accessed in relation to the study are appropriately anonymised, no further ethical review was required.

The UK GDPR legal basis for processing NHS England data are: Article 6:1(e):This project is a task in the public interest because it was commissioned by the Department of Health to evaluate the impact of home-visiting interventions on child maltreatment; and, Article 9:2(j):This is scientific research which uses only the data required to answer these important research aims, using a data safe haven to protect the data and outputs this research will directly influence policy making regarding home visiting programmes to benefit the UK public.

DATA SUBJECTS

The cohort consists of 1645 women (and their first-born child(ren)) who met eligibility criteria for participation in the Building Blocks trial of the Family Nurse Partnership (FNP) and were nulliparous (a woman who has never given birth either by choice or for any other reason. This term also applies to women who have given birth to a stillborn baby, or a baby who was otherwise not able to survive outside the womb) women aged 19 or under, living in one of 18 local authority FNP catchment areas in England who were recruited by 24+6 weeks gestation, had conversational level of English and were able to consent to research.

Women were recruited by locally-based research professionals usually employed by local NHS organisations following identification through NHS maternity units. Women provided their written informed consent to participate including for data in their administrative health records to be provided to the research team.

Relevant Data for the study cohort provided by NHS England under DARS-NIC-333498-D1K7G-v4.4 include: Civil Registrations of Death; Hospital Episode Statistics A&E; Outpatients; and, Admitted Patient Care. These data were used to follow-up mothers recruited into the study and their babies, up until the baby’s second birthday. These datasets are the main source of data for two of the primary outcomes (and several secondary outcomes).

The BB:0-2 trial began in 2009 and the findings which cover the period from pregnancy to the child’s second birthday' were published in October 2015 and available here: https://doi.org/10.1016/S0140-6736(15)00392-X

The National Institute of Health Research funded BB:2-6 study follow up study examined child outcomes to age six, building on the original study examining the longer term impact of FNP intervention. A subsequent application for data from NHS England (DARS-NIC-333498-D1K7G) permitted collection of the same health data for an additional four years, until the mother’s first child(ren) was aged six years old. As identifiable data were required to enable linkage of the original trial cohort data to these new records, section 251 approval was given.

The Building Blocks study originally involved a lay group who advised on aspects of trial delivery and provided input into the design and setup of the study. An independent group of young people also provided advice to the research team and a lay perspective on the general management and delivery of the project and in particular the preparation of the outputs from the study.

Expected output

The results will be of relevance to many different audiences: policymakers at the Department for Education (DfE) and at Department for Health and Social Care (DHSC), and at Public Health England (PHE) in England; at the “National Centre on Early Prevention” (Nationales Zentrum Frühe Hilfen, NZFH), the Ministry for Social Affairs, Health, Women and Family in the German Republic of Saarland and the Federal Ministry of Family Affairs, Senior Citizens, Women and Youth in Germany; the National Health Service (NHS) in England; think tanks; local authorities; practitioners; advocacy groups; media and commentators; and the academic community across several disciplines, ranging from economics to psychology and child development.

The main academic project outputs will be at least two journal articles (one for each study analysis). For the two main publications the study team will target two top economics journals. Upon project completion and in adherence with the publication plan, the study team will consider submitting specific findings for publication in child development or public health journals, to facilitate dissemination to a wider audience. The publication of the report will be advertised through a press release, and the study team will also organize an end-of-project workshop, where academics, practitioners and representatives from FNP, DfE, DHSC, PHE and NHS will be invited to discuss the implications of the findings. To make sure this will reach out to the relevant policy circles, the study team will exploit the fact that the Principal investigator is a Trustee of the Foundation Years Information and Research Group. The Group devoted its yearly seminar series in 2016/2017 to the FNP, and visited the Ministry for Social Affairs, Health, Women and Family in the German Republic of Saarland to study their home visiting programmes in January 2018.

All access for analysis is to anonymised data.. No identifiable data will be accessed. Published results will only contain aggregated data with small numbers suppressed. All outputs will be aggregated with small numbers suppressed in line with the HES Analysis Guide.

Initial (main) academic outputs and secondary outputs were expected by Summer 2022. Most analyses have been completed but some remain. To allow for completion of the analysis, including the necessity to respond to peer review feedback on outputs, the study team wish to extend the DSA to October 2025.

Benefits reported

The original Building Blocks trial (BB:0-2) provided evidence for the short-term effectiveness of the programme (up to 2 years after birth). The Building Blocks: 2-6 (BB:2-6) study has now provided evidence for the medium-term effectiveness and costs of one of the most promising early intervention programmes for reducing risk of child maltreatment in a targeted vulnerable population. Both studies have provided evidence which has informed policy decision-making at both national and local level about whether to continue implementing the programme and also changes to programme content, format and delivery.

The study team may be in a position to report further yielded benefits following completion of the analysis when main, and secondary outputs have been published and peer reviewed.

DARS-NIC-374907-Q5W5W-v0.6 1 November 2020 to 31 October 2023
Title
Exploring the mechanisms through which specialist home visiting produces health and well-being benefits for families.
Commercial
No
Sublicensing
No
Datasets
5
Files released
0

Datasets: Civil Registrations of Death - Secondary Care Cut; HES:Civil Registration (Deaths) bridge; Hospital Episode Statistics Accident and Emergency (HES A and E); Hospital Episode Statistics Admitted Patient Care (HES APC); Hospital Episode Statistics Outpatients (HES OP)

Objective for processing

(i) Specialist home visiting to support new families:

The Family Nurse Partnership (FNP) was developed and licensed by the University of Colorado as a voluntary, preventive programme for vulnerable young first time mothers. It offers intensive and structured home visiting, delivered by specially trained nurses, from early pregnancy until age two. The three aims are: to improve pregnancy outcomes, improve child health and development and improve parents’ economic self-sufficiency.

A strong and rigorous US evidence base, developed over 30 years, has shown FNP benefits the neediest young families in the short, medium, and long term across a wide range of outcomes helping improve social mobility and break the cycle of inter-generational disadvantage and poverty.

(ii) Work to establish the programme in the UK and the Cardiff evaluations:

The programme was adapted for implementation and introduced in England in 2007. Due to the greatly differing nature of publicly funded health and social care service provision and socio-cultural context between England and the US, the relative benefits of the programme need to be replicated in England and costs determined before wide-spread implementation can be recommended. The study team have conducted two definitive evaluations:

BB:0-2 - Department of Health and Social Care (DHSC) commissioned the ‘Building Blocks’ randomised controlled trial (RCT) from Cardiff University to provide independent evidence on the effectiveness of the FNP programme in improving short term outcomes for young parents and their babies. The trial began in 2009 and the findings which cover the period from pregnancy to the child’s second birthday' were published in October 2015. The FNP described these as “important early findings and add to the evidence the study team have from the US, Netherlands and other early evaluation in England to help improve FNP in England.”

BB: 2-6 - The National Institute of Health Research further funded Cardiff University to undertake a follow up study to examine child and maternal outcomes to age six. This built on the original study to examine the longer-term impact of FNP intervention. Its principal objective was to determine the effectiveness of the FNP programme in reducing objectively measured long-term maltreatment outcomes when compared to usually provided health and social care alone. The main research outcomes were child in need status, child protection registration, referral to social care. Other indicators of programme impact included measures of injuries and ingestions and hospital DNA rates. The study report has been externally peer reviewed and a final version will be published by NIHR in November 2020.

In the BB:2-6 study, Cardiff University followed-up the cohort of mothers and children who took part in the first Building Blocks trial (BB:0-2) by obtaining health and mortality data from NHS Digital, data from Department for Education (DfE) and data from the Department of Health (abortion statistics) and linked with the original trial data.

(iii) Evidence from the Cardiff work and NHS Digital supplied data to date

The original Building Blocks trial (BB:0-2) provided evidence for the short-term effectiveness of the programme (up to 2 years after birth). The Building Blocks: 2-6 (BB:2-6) study has now provided evidence for the medium-term effectiveness and costs of one of the most promising early intervention programmes for reducing risk of child maltreatment in a targeted vulnerable population. Specifically, data requested from NHS Digital provided the basis for key study outcomes which are indicators of maltreatment. Both studies have provided evidence which has informed policy decision-making at both national and local level about whether to continue implementing the programme and also changes to programme content, format and delivery.

(iv) Newly funded work 2019/20:

This new request reflects the receipt of additional funding to analyse the existing pseudonymised study data already held in the data safe haven (which includes NHS Digital supplied data). The newly funded analyses will explore the mechanisms by which specialist home visiting may have its effect for recipient families. Two funders (Nuffield Foundation, European Research Council (ERC)) have provided resource to support the two separate analyses both of which will utilise the same existing data set.

Proposed analyses funded by ERC and Nuffield Trust:

The newly funded analyses will explore the mechanisms by which specialist home visiting may have its effect for recipient families. The analyses to date have determined the impact of the home visiting intervention upon a wide range of family outcomes. These range from the antenatal period through to early in children’s school life (i.e. at key stage 1). The study team have explored how home visiting has benefited some families but been less effective for others. The study team have also assessed the additional benefit that receiving more home visits has had for some of the more important outcomes that have been assessed. The study team have explored the perceptions of both mothers and family nurses (i.e. the professionals who deliver home visits to families) about how the home visiting may exert its effect (and what may be a barrier to its effectiveness). The study team have explored how some outcomes (such as children being designated as In Need by local departments of children’s services) are influenced by a range of potential risk factors (for example, attributes of the mother and child).

The new analysis will take an econometric approach to explore how the benefits of the home visiting intervention are produced. It will explore the mechanisms through which the home visiting intervention is hypothesised to produce benefits (for example, whether expected changes in maternal behaviour occur and whether these then lead to other improvements). It will explore how characteristics of nurses plays any part in observed effects (for example, whether some nurses are associated with more or less improvement. This may be due to differences in clinical experience or training, for example). It will explore further how home visiting dose and quality may be linked to differential family benefits (visit-level data available for each mother in receipt of specialist home-visiting provides detail on how many visits were delivered, their duration and the content addressed using the scheme’s standard monitoring form). Finally, it will also assess how reported use of other public sector services may also have an influence. The existing trial cohort data (including that derived from the NHS via NHS Digital) will be analysed using state-of-the-art economics methods, benefiting from the input of the lead investigator who has secured the additional funding. The analysis will be able to model dynamically the study data to establish more clearly than has been possible previously how the home visiting programme produces benefits for families.

These two analyses (Nuffield and ERC) will both use the existing pseudonymised data set. The first (Nuffield), will involve two similar study cohorts being assessed in the new analyses (the other being from a study in Germany which implemented a similar intervention). The analyses for the two cohorts will be run in parallel (i.e. the data will remain where currently located) but similar research questions will be asked of the two study datasets. No UK data currently held by Cardiff as data controller will be shared or linked to the German data. Only results will be compared when interpreting the outputs from the two analyses. The second funded analysis (ERC), will involve a broader range of data drawn from a variety of sources these will include: distance from / price of / availability of goods and services for children (e.g. price of toys, distance from GP/parks, food prices); and prices of cigarettes, alcohol and local wages. Like the Nuffield funded work, the ERC analyses will involve data from the Building Blocks trial cohort being analysed separately from any other project data but will share a common underlying research question and specialist economics methods. For the analysis of the Building Blocks dataset more detailed exploration of (non-NHS) trial data based on existing post code will be used to determine the role of local context (including policies) upon family outcomes, no attempt will made to identify or link the data.

The two new project grants are led by a member of staff at UCL and the analyses will be undertaken by the research fellow and themselves, both of whom are substantive employees of UCL and hold honorary titles with Cardiff University for the duration of the studies. Access will be as described above, and access will be approved by the study lead at Cardiff University. All analyses will be reviewed and approved by the study lead at Cardiff University. This study lead is the chief investigator and is costed into both grants to provide these approvals and oversee all outputs from the additionally funded work. A statistician based in Cardiff and currently approved to access the cohort dataset will have responsibility to review the statistical analysis plan for both Nuffield and ERC-funded studies.

Cardiff University was the Data Controller (and sponsor) of the original study and Swansea University (and Cardiff University) were Data Processors. This new application will also include UCL as a joint controller and processor. The additional funded work is funded by both the European Research Council and Nuffield Trust. Neither body may make decisions related to how the data are processed and will not have access to the data. The Chair of the Information Governance Review Panel at SAIL has confirmed that as the data being accessed in relation to the newly funded work are appropriately anonymised, no further ethical review is required.

Cardiff University

Article 6:1(e):This project is a task in the public interest because it was commissioned by the Department of Health to evaluate the impact of home-visiting interventions on child maltreatment.

Article 9:2(j):This is scientific research which uses only the data required to answer these important research aims, using a data safe haven to protect the data and outputs this research will directly influence policy making regarding home visiting programmes to benefit the UK public.

University College London

Article 6(1)(e) of the General Data Protection Regulations (GDPR), i.e. “a task carried out in the public interest”. It also falls under Article 9(2)(j), “processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes”.

(v) Clarification about data subjects

The data subjects were 1645 women (and their first-born child(ren)) who met eligibility criteria for participation in the Building Blocks trial of the Family Nurse Partnership (FNP) and were nulliparous (a woman who has never given birth either by choice or for any other reason. This term also applies to women who have given birth to a stillborn baby, or a baby who was otherwise not able to survive outside the womb) women aged 19 or under, living in one of 18 local authority FNP catchment areas in England who were recruited by 24+6 weeks gestation, had conversational level of English and were able to consent to research.

Women were recruited by locally-based research professionals usually employed by local NHS organisations following identification through NHS maternity units. Women provided their written informed consent to participate including for data in their administrative health records to be provided to the research team.

Relevant cohort data provided for trial by NHS Digital were Inpatient, Outpatient, A&E datasets and used to follow-up mothers recruited into the study and their babies, up until the baby’s second birthday. These datasets were the main source for two of the primary outcomes (and several secondary outcomes).

The BB:0-2 trial began in 2009 and the findings which cover the period from pregnancy to the child’s second birthday' were published in October 2015.

The National Institute of Health Research funded BB:2-6 study follow up study examined child outcomes to age six, building on the original study examining the longer term impact of FNP intervention. A subsequent application for data from NHS Digital (DARS-NIC-333498-D1K7G) permitted collection of the same health data for an additional four years, until the mother’s first child(ren) was aged six years old. As identifiable data were required to enable linkage of the original trial cohort data to these new records, section 251 approval was given.

The Building Blocks study originally involved a lay group who advised on aspects of trial delivery and provided input into the design and setup of the study. An independent group of young people also provided advice to the research team and a lay perspective on the general management and delivery of the project and in particular the preparation of the outputs from the study.

Expected output

The results will be of relevance to many different audiences: policymakers at the Department for Education (DfE) and at Department for Health and Social Care (DHSC), and at Public Health England (PHE) in England; at the “National Centre on Early Prevention” (Nationales Zentrum Frühe Hilfen, NZFH), the Ministry for Social Affairs, Health, Women and Family in the German Republic of Saarland and the Federal Ministry of Family Affairs, Senior Citizens, Women and Youth in Germany; the National Health Service (NHS) in England; think tanks; local authorities; practitioners; advocacy groups; media and commentators; and the academic community across several disciplines, ranging from economics to psychology and child development.

The main academic project outputs will be at least two journal articles (one for each study analysis). For the two main publications the study team will target two top economics journals. Upon project completion and in adherence with the publication plan, the study team will consider submitting specific findings for publication in child development or public health journals, to facilitate dissemination to a wider audience. The publication of the report will be advertised through a press release, and the study team will also organize an end-of-project workshop, where academics, practitioners and representatives from FNP, DfE, DHSC, PHE and NHS will be invited to discuss the implications of the findings. To make sure this will reach out to the relevant policy circles, the study team will exploit the fact that the Principal investigator is a Trustee of the Foundation Years Information and Research Group. The Group devoted its yearly seminar series in 2016/2017 to the FNP, and visited the Ministry for Social Affairs, Health, Women and Family in the German Republic of Saarland to study their home visiting programmes in January 2018.

All access for analysis is to pseudonymised data, no identifiable data will be accessed. Published results will only contain aggregated data with small numbers suppressed. All outputs will be aggregated with small numbers suppressed in line with the HES Analysis Guide.

Initial (main) academic outputs will be expected to be available by end 2021. Secondary outputs will be available by Summer 2022.

Benefits reported

The original Building Blocks trial (BB:0-2) provided evidence for the short-term effectiveness of the programme (up to 2 years after birth). The Building Blocks: 2-6 (BB:2-6) study has now provided evidence for the medium-term effectiveness and costs of one of the most promising early intervention programmes for reducing risk of child maltreatment in a targeted vulnerable population. Both studies have provided evidence which has informed policy decision-making at both national and local level about whether to continue implementing the programme and also changes to programme content, format and delivery.

Register history

When this agreement appeared in, or was edited in, each monthly edition of the register. Built by comparing every edition this site holds, the earliest of which is July 2021.

Cite this page

NHS England (2026) Data Uses Register, September 2026 edition, agreement DARS-NIC-374907-Q5W5W, “Exploring the mechanisms through which specialist home visiting produces health and well-being benefits for families.”. Read via NHS Data Access Explorer (unofficial), https://healthdatauses.uk/agreements/dars-nic-374907-q5w5w/ (accessed [date]).

This address stays the same, but the page is rebuilt with each monthly edition, so the citation names the edition it shows. Every edition's data is kept in the facts store.

Source: datausesregister_september2026.xlsx, September 2026 edition of the NHS England Data Uses Register. Search that workbook for DARS-NIC-374907-Q5W5W to see the original rows.